Peptide Science Platform

Bioactive
Peptides,
Explained.

Evidence-based education on the peptides reshaping modern wellness, recovery, and longevity research.

0
Peptides Documented
0
Research Categories
0
Cited Studies
0
FDA-Approved Peptides
Find Your Peptide

What are you
researching?

Pick a focus area and jump straight to the relevant peptides.

USA Tested
Third-Party Verified
HPLC Purity Verification
Batch-Specific COAs


Eight Research
Domains. One Platform.

Browse all peptides
Body Composition

Growth hormone secretagogues, fat-targeting fragments, and GHRH analogs studied for lean mass, lipolysis, and metabolic optimization.

Explore category
Healing & Recovery

Tissue repair, anti-inflammatory, and angiogenic peptides.

Cognitive Enhancement

Neuropeptides for memory, focus, and neuroplasticity.

Anti-Aging & Longevity

Telomere, mitochondrial, and bioregulator peptides.

Immune Support

Thymic and antimicrobial peptides for immune modulation.

Skin & Hair

Copper peptides and growth factors for dermal repair.

A Alanine R Arginine N Asparagine D Aspartate C Cysteine E Glutamate Q Glutamine G Glycine H Histidine I Isoleucine L Leucine K Lysine M Methionine F Phenylalanine P Proline S Serine T Threonine W Tryptophan Y Tyrosine V Valine


How Peptides
Work

Peptides are short chains of amino acids that act as precise signaling molecules. Unlike broad-spectrum drugs, they interact with specific receptors to direct targeted biological responses.

Each node represents an amino acid in a peptide chain.

01 / Structure
Amino Acid Sequences with Biological Precision

Peptides are defined as chains of 2 to 50 amino acids linked by peptide bonds. Their sequence determines their three-dimensional structure, which in turn determines which receptors they can bind. This specificity is why peptides can produce targeted effects that broad-molecule drugs often cannot.

02 / Signaling
Receptor Binding and Downstream Cascades

When a peptide binds to its target receptor, it initiates signaling cascades: phosphorylation events, gene transcription changes, enzyme activation, or ion channel modulation. Growth hormone secretagogues, for example, bind GHS-R1a receptors on pituitary cells to trigger GH pulse amplification via cyclic AMP.

03 / Endogenous Origins
Many Are Derived from Naturally Occurring Compounds

Most research peptides are derived from or modeled after peptides the human body naturally produces. BPC-157 comes from a gastric protein; Epithalon from the pineal gland; GHK-Cu from human plasma. This endogenous basis often correlates with favorable safety profiles relative to synthetic drugs.

04 / Research Status
From Preclinical Models to Clinical Trials

Peptide research spans a spectrum: from in vitro cell studies, through animal models, to Phase I-III human clinical trials. Some peptides have reached FDA approval (Tesamorelin, Bremelanotide), while others have regulatory approval in specific countries. Understanding a peptide's research status is essential for accurate risk assessment.

05 / Stability & Delivery
Administration Routes and Bioavailability Considerations

Most peptides are rapidly degraded by gastrointestinal enzymes, making oral bioavailability a challenge. Research primarily uses subcutaneous or intramuscular injection for systemic action. Exceptions include KPV (orally stable), Dihexa (lipophilic, crosses BBB), and intranasal peptides like Semax and Selank. Delivery technology continues to advance.

 

Why Peptide Science
Is Rapidly Advancing

Peptides occupy a unique space in biomedical research: highly specific, naturally derived, and increasingly clinically validated.

Receptor Specificity

Peptides bind to specific receptors with high selectivity, producing targeted biological effects that broad-spectrum drugs cannot achieve. This selectivity often translates to fewer off-target side effects.

Endogenous Origins

Many research peptides are modifications of peptides the body naturally produces. This endogenous basis often confers biological compatibility and reduces the risk of immune rejection or foreign-molecule reactions.

Diverse Mechanisms

Peptides can activate receptors, inhibit enzymes, modulate gene expression, or act as neurotransmitters. This mechanistic diversity makes them applicable across virtually every organ system in the body.

Gene-Level Effects

Certain peptides, like GHK-Cu and Epithalon, operate at the genomic level, resetting gene expression patterns toward healthier states. This represents a fundamentally different class of intervention than conventional pharmacology.

Growing Clinical Base

From Tesamorelin's FDA approval for body composition to Thymosin Alpha-1's use in 37 countries, peptides are graduating from preclinical research to approved therapeutics at an accelerating pace.

Metabolic Degradation

Unlike small molecules that accumulate, peptides are metabolized into constituent amino acids. This metabolic pathway eliminates the accumulation toxicity concerns associated with many conventional drugs.



Browse the
Peptide Library

Body Composition
Ipamorelin

The most selective GH secretagogue

Preclinical + Phase I completed 6 benefits
Cognitive Enhancement
Semax

Russia's premier cognitive enhancement peptide

Approved medication in Russia and Ukraine 6 benefits
Skin & Hair
GHK-Cu

Copper-bound peptide that resets tissue to a younger state

Used in cosmetic products; extensive human studies 7 benefits
Immune Support
Thymosin Alpha-1

The thymus gland's master immune modulator

Approved in 37+ countries (Zadaxin) 6 benefits
Anti-Aging & Longevity
Epithalon

Telomerase-activating peptide with longevity research

Extensive Russian clinical studies; 15+ years of human data 6 benefits
Cognitive Enhancement
Selank

Anxiolytic and nootropic with immune modulation

Approved medication in Russia 6 benefits
Healing & Recovery
TB-500

Systemic healing and anti-inflammatory signaling

Phase II clinical trials (cardiac applications) 6 benefits
Body Composition
Tesamorelin

The only FDA-approved peptide for visceral fat reduction

FDA-approved (Egrifta) 6 benefits
Sleep & Recovery
DSIP

Sleep architecture regulation and stress resilience

Preclinical + limited Eastern European human studies 6 benefits
Sexual Health
PT-141

FDA-approved centrally-acting sexual dysfunction treatment

FDA-approved (Vyleesi, 2019) 6 benefits
Anti-Aging & Longevity
Humanin

Mitochondrial peptide protecting against neurodegeneration and aging

Active preclinical; emerging human research 6 benefits
Healing & Recovery
KPV

Potent anti-inflammatory with gut healing and skin repair properties

Preclinical (IBD and wound healing models) 6 benefits

Use the arrows to browse. Click any card for the full research profile.

From the Axiom Labz Shop

Research-grade
peptides, verified.

Third-party tested, batch-specific COAs, HPLC purity verification. Browse the full catalog on the Axiom Labz store.

Shop All Products

For research use only. Not for human consumption.


Latest Research

Peer-Reviewed
Evidence

Full research database
New England Journal of Medicine

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)

In this 68-week, double-blind, randomized trial of 1,961 adults, once-weekly semaglutide 2.4 mg produced a mean body-weight reduction of 14.9% versus 2.4% with placebo, alongside improvements in cardiometabolic risk factors.

Semaglutide Human RCT
2021
New England Journal of Medicine

Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)

A 72-week phase 3 trial of 2,539 adults without diabetes; the dual GIP/GLP-1 receptor agonist tirzepatide achieved mean weight reductions of up to 20.9% at the 15 mg dose, the largest yet reported for a pharmacologic agent at the time.

Tirzepatide Human RCT
2022
New England Journal of Medicine

Metabolic Effects of a Growth Hormone–Releasing Factor in Patients with HIV

The pivotal trial supporting FDA approval of tesamorelin: in HIV patients with abdominal fat accumulation, tesamorelin significantly reduced visceral adipose tissue and triglycerides over 26 weeks without worsening glucose tolerance.

Tesamorelin Human RCT
2007
Obstetrics & Gynecology

Bremelanotide for Hypoactive Sexual Desire Disorder (RECONNECT)

Two phase 3 randomized trials supporting FDA approval of bremelanotide (PT-141): the melanocortin agonist significantly improved sexual desire and reduced associated distress in premenopausal women with HSDD.

Bremelanotide (PT-141) Human RCT
2019
The Lancet

Once-Weekly Cagrilintide for Weight Management — A Phase 2 Trial

The long-acting amylin analogue cagrilintide produced dose-dependent weight loss up to 10.8% over 26 weeks in adults with overweight or obesity, supporting amylin agonism as a distinct anti-obesity mechanism.

Cagrilintide Human RCT
2021
Cell Metabolism

The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance

The foundational MOTS-c paper: this mitochondrial-derived peptide regulates the folate–AMPK pathway, enhancing insulin sensitivity and protecting against diet-induced obesity in mouse models.

MOTS-c Animal Study
2015
International Journal of Molecular Sciences

Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data

A comprehensive review of the copper tripeptide GHK-Cu, documenting its modulation of thousands of human genes toward tissue remodeling, wound healing, anti-inflammatory and antioxidant activity.

GHK-Cu In Vitro Human Study
2018
Critical Care

The Efficacy of Thymosin Alpha-1 for Severe Sepsis (ETASS): a multicenter, randomized controlled trial

In 361 patients with severe sepsis, thymosin alpha-1 produced a reduction in 28-day all-cause mortality and improved monocyte HLA-DR expression, supporting its immunomodulatory role.

Thymosin Alpha-1 Human RCT
2013
Current Pharmaceutical Design

Stable Gastric Pentadecapeptide BPC 157 in Trials for Inflammatory Bowel Disease and Healing

A review of the extensive preclinical literature on BPC-157, summarizing its angiogenic, cytoprotective and tendon/ligament/gut healing effects across numerous rodent injury models.

BPC-157 Animal Study
2018
Bulletin of Experimental Biology and Medicine

Peptide Promotes Overcoming of the Division Limit in Human Somatic Cell Cultures

The Khavinson group reported that the tetrapeptide Epitalon (Epithalon) induced telomerase activity and telomere elongation in human somatic cells, allowing them to surpass the Hayflick division limit in culture.

Epithalon In Vitro Human Study
2003
Journal of Clinical Endocrinology & Metabolism

Prolonged Stimulation of GH and IGF-I Secretion by CJC-1295, a Long-Acting Analog of GHRH, in Healthy Adults

Single injections of CJC-1295 produced sustained, dose-dependent increases in growth hormone (2–10×) and IGF-I lasting 6+ days, with a half-life supporting once-weekly dosing.

CJC-1295 Human Clinical Study
2006
European Journal of Endocrinology

Ipamorelin, the First Selective Growth Hormone Secretagogue

Ipamorelin stimulated growth hormone release with potency comparable to GHRP-6 but without the ACTH and cortisol elevations seen with other secretagogues, defining its selective profile.

Ipamorelin Animal Study
1998
Nature

Thymosin β4 Activates Integrin-Linked Kinase and Promotes Cardiac Cell Migration, Survival and Repair

Thymosin beta-4 (the parent of TB-500) promoted cardiomyocyte survival and migration and improved cardiac function after coronary artery ligation in mice, establishing its tissue-repair signaling.

TB-500 (Thymosin β4) Animal Study
2004
Journal of Clinical Endocrinology & Metabolism

The Effects of a Synthetic Fragment of Human Growth Hormone (AOD-9604) on Lipid Metabolism

The C-terminal hGH fragment AOD-9604 stimulated lipolysis and inhibited lipogenesis in vitro and in obese animal models without the diabetogenic effects of intact growth hormone.

AOD-9604 Human Clinical Study
2001
Cellular Immunology

A Comprehensive Summary of LL-37, the Factotum Human Cathelicidin Peptide

A review of LL-37, the only human cathelicidin, detailing its broad-spectrum antimicrobial activity, immunomodulation, angiogenesis and wound-healing roles.

LL-37 In Vitro Human Study
2012
Zh Nevrol Psikhiatr Im S.S. Korsakova

Efficacy and Safety of the Anxiolytic Selank in the Treatment of Generalized Anxiety and Neurasthenia

In a comparative clinical study, the heptapeptide Selank showed anxiolytic efficacy comparable to benzodiazepines (medazepam) without the sedation, dependence or withdrawal liabilities.

Selank Human Clinical Study
2008
Journal of Histochemistry & Cytochemistry

Semax, an Analogue of ACTH(4-10), Increases BDNF Levels in the Rat Hippocampus

Intranasal Semax elevated BDNF and trkB expression in the hippocampus, providing a molecular basis for its reported neuroprotective and cognitive-enhancing effects.

Semax Animal Study
2006


Stay Informed on
Peptide Research

Research summaries, newly documented peptides, and clinical trial updates delivered to your inbox.

No spam. Unsubscribe at any time.